Cell and Gene Therapy News

$5 million grant to expand blood cancer therapy optionsYesterday
Using a new grant from the Leukemia and Lymphoma Society, a team from Baylor College of Medicine will work to develop more widely applicable targeted cellular therapies for leukemia and lymphoma.
‘Homing system’ targets therapeutic T cells to brain cancerSep 5, 2018
A multi-institution international team led by researchers at Baylor College of Medicine has developed a new strategy to overcome one of the main obstacles in the treatment of brain cancer – access to the tumor. 
Engineered T cells made to recognize tumor-specific patternsJun 26, 2018
Researchers have found a new way to ensure that engineered T cells can reliably discriminate between normal and malignant cells.
Immunotherapy summit brings together patients, expertsJan 11, 2018
The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Two Baylor College of Medicine faculty members named to National Academy of MedicineOct 17, 2016
Dr. Malcolm Brenner and Dr. Cheryl Walker were elected to membership in the National Academy of Medicine.
Special T cells that target solid tumors offer potential treatment for pediatric and adult cancersSep 14, 2016
A new study by researchers at Baylor College of Medicine and Texas Children’s Cancer Center has shown promising results for the use of adoptive cell-therapies to treat pediatric and adult solid tumor cancers.
One-time treatment rescues lethal metabolic liver disease in miceAug 30, 2016
Researchers have shown in mice that deleting a gene associated with liver disorder tyrosinaemia type I, they can turn the once deadly illness benign.
T cells that target two tumor surface molecules mitigate tumor escape in mouse model of glioblastomaJul 18, 2016
Researchers show a new strategy, based on targeting specific surface molecules, that eliminates most of the cancer cells in a mouse model of glioblastoma.
Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatmentJun 17, 2016
Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responsesJun 6, 2016
Treating B cell malignancies with the patients’ own T cells modified so as to target specific B cell markers has shown clinical success.